Overnight mesothelial cell exfoliation: A magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 28, Issue SUPP. 3, 2008, Pages

  Kanjanabuch, Talerngsak ^a   Siribamrungwong, Monchai ^b   Khunprakant, Rungrote ^a   Kanjanabuch, Sirigul ^a   Jeungsmarn, Piyathida ^c   Achavanuntakul, Bunlusak ^d   Pongpirul, Krit ^e   Park, Min Sun ^f   Tungsanga, Kriang ^a   Eiam Ong, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Trat Hospital   (Thailand)

^c Ban Phaeo Hospital   (Thailand)

^d Sappasitthiprasong Hospital   (Thailand)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f Renal Asia   (South Korea)

Author keywords

CA125; Cancer antigen 125; CAPD; Continuous ambulatory peritoneal dialysis; Exfoliated mesothetial cells; Mesothelial cell mass; Ultrafiltration failure

Indexed keywords

CA 125 ANTIGEN; CREATININE; CYTOKERATIN; GLUCOSE; SODIUM;

ADULT; APOPTOSIS; CELL COUNT; CELL LOSS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIALYSATE; DIALYSATE LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MALE; MESOTHELIUM CELL; NICK END LABELING; NUTRITIONAL STATUS; PERITONEUM CELL; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; ULTRAFILTRATION;

ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CA-125 ANTIGEN; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEAL DISEASES; PERITONEUM; PROGNOSIS; TIME FACTORS; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 48749107447     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Lo WK. What factors contribute to differences in the practice of peritoneal dialysis between Asian countries and the West? Perit Dial Int 2002; 22:249-57.
2. Wang T, Abraham G, Akiba T, Blake P, Gokal R, Kim MJ, et al. Peritoneal dialysis in Asia in the 21st century: perspectives on and obstacles to peritoneal dialysis therapy in Asian countries. Perit Dial Int 2002; 22:243-8.
3. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11:498-506.
4. Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, Krediet RT. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study. Perit Dial Int 2004; 24:562-70.
5. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
6. Dobbie JW. New concepts in the molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15:97-109.
7. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7:171-91.
8. Ogata S, Naito T, Yorioka N, Kiribayashi K, Kuratsune M, Kohno N. Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant 2004; 19:2831-7.
9. Nagy JA. Peritoneal membrane morphology and function. Kidney Int Suppl 1996; 56:S2-11.
10. Gotloib L, Wajsbrot V, Shostak A. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin. Nephron 2002; 92:142-55.
11. Lameire N, Biesen VW, Landschoot MV, Wang T, Heimbürger O, Bergström J, et al. Experimental models in peritoneal dialysis: a European experience. Kidney Int 1998; 54:2194-206.
12. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT on behalf of the Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88:S43-9.
13. Cameron GR, Hassan SM, De SN. Repair of Glisson's capsule after tangential wounds of the liver. J Path Bact 1957; 73:1-10.
14. Twardowski ZJ, Nolph K, Khanna R, Prowant B, Ryan L, Moore H, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
15. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S5-21.
16. Lai KN, Lai KB, Szeto CC, Ho KK, Poon P, Lam CW, et al. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis 1997; 29:699-705.
17. Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beelen RH, Krediet RT. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10:64-9.
18. Koomen GC, Betjes MG, Zemel D, Krediet RT, Hoek FJ. Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14:132-6.
19. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21:560-7.
20. Passadakis P, Panagoutsos S, Thodis E, Tsivara I, Sopassi F, Kartali S, et al. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 1999; 15:40-4.
21. Ho-dac-Pannekeet MM, Krediet RT. Inflammatory changes in vivo during CAPD: what can the effluent tell us? Kidney Int 1966; 50(Suppl 56):S12-16.